tiprankstipranks
Trending News
More News >
Newron Pharmaceuticals SpA (CH:NWRN)
:NWRN

Newron Pharmaceuticals SpA (NWRN) Similar Stocks

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Newron Pharmaceuticals SpA
CHF22.85
CHF456.11M
19.75
178.56%
2 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.37
CHF142.32M
-2.11
-26.03%
0 Buy
1 Hold
0 Sell
Hold
Basilea Pharmaceutica
CHF54.50
CHF663.84M
9.23
34.14%
2 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF4.56
CHF1.13B
-6.62
506.16%
2 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF12.34
CHF172.40M
-2.51
12.76%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF23.90
CHF139.58M
4.49
-6.20%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:NWRN
Newron Pharmaceuticals SpA
23.65
15.16
178.56%
CH:MOLN
Molecular Partners AG
3.43
-1.21
-26.03%
CH:BSLN
Basilea Pharmaceutica
55.20
14.05
34.14%
CH:IDIA
Idorsia Ltd
4.42
3.69
505.48%
CH:SANN
Santhera Pharmaceuticals Holding
12.90
1.46
12.76%
CH:XLS
Xlife Sciences Ltd.
24.20
-1.60
-6.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts